Aurolife Pharma LLC
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 6 Wheeling Road, Dayton, New Jersey (NJ) 08810, United States (USA)
- Operations here
- analysislabelpackrelabelrepack
- FDA identifiers
- FEI 3005796917 · DUNS 078296263
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2021-12-07
- VAIDrug Quality Assurance2019-10-22
- VAIDrug Quality Assurance2018-06-14
- NAIDrug Quality Assurance2016-07-28
- NAIDrug Quality Assurance2016-01-12
- NAIDrug Quality Assurance2015-07-09
- VAIDrug Quality Assurance2013-10-15
- VAIDrug Quality Assurance2011-11-02
- VAIDrug Quality Assurance2011-05-25
- NAIDrug Quality Assurance2009-05-11
Drugs this plant is listed as making
7 distinct drugs across 28 products name this site in their FDA label.
- GabapentinAurobindo Pharma Limited
- MirtazapineAurolife Pharma LLC
- Montelukast SodiumAurobindo Pharma Limited
- OlanzapineAurobindo Pharma Limited
- Phentermine HydrochlorideAurolife Pharma, LLC
- Valacyclovir HydrochlorideAurobindo Pharma Limited
- ValsartanAurobindo Pharma Limited
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.